Aditxt Acquires Ignite Proteomics for $36 Million
Aditxt announced the acquisition of Ignite Proteomics. Under the terms of the transaction documents, Aditxt acquired Ignite in a transaction providing 36,000 shares of Aditxt's newly designated Series A-2 Convertible Preferred Stock, representing an aggregate stated value of $36M, subject to the terms of the Certificate of Designation.
